Literature DB >> 16696644

Phenotypic switching and its implications for the pathogenesis of Cryptococcus neoformans.

Neena Jain1, Abraham Guerrero, Bettina C Fries.   

Abstract

Phenotypic switching has been described in several strains of Cryptococcus neoformans. It occurs in vivo during chronic infection and is associated with differential gene expression and changes in virulence. The switch involves changes in the polysaccharide capsule and cell wall that affect the yeast's ability to resist phagocytosis. In addition, the phenotypic switch variants elicit qualitatively different inflammatory responses in the host. The host's immune response ultimately affects selection of the switch variants in animal models of chronic cryptococcosis. The biological relevance of phenotypic switching is demonstrated in several murine infection models and further underlines the importance of phenotypic switching in the setting of human disease. This includes the association of switching and poor outcome in chronic infection, the ability of the mucoid variant of strain RC-2 (RC-2 MC) but not the smooth variant (RC-2 SM) to promote increased intracranial pressure in a rat model, and lastly the observation that antifungal interventions can promote the selection of more virulent switch variants during chronic murine infection.

Entities:  

Mesh:

Year:  2006        PMID: 16696644      PMCID: PMC2745630          DOI: 10.1111/j.1567-1364.2006.00039.x

Source DB:  PubMed          Journal:  FEMS Yeast Res        ISSN: 1567-1356            Impact factor:   2.796


  55 in total

1.  Analysis of the role of recA in phenotypic switching of Pseudomonas tolaasii.

Authors:  H Sinha; A Pain; K Johnstone
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

Review 2.  Current approach to the acute management of cryptococcal infections.

Authors:  W G Powderly
Journal:  J Infect       Date:  2000-07       Impact factor: 6.072

3.  A yeast prion provides a mechanism for genetic variation and phenotypic diversity.

Authors:  H L True; S L Lindquist
Journal:  Nature       Date:  2000-09-28       Impact factor: 49.962

4.  Phenotypic switching in Candida glabrata involves phase-specific regulation of the metallothionein gene MT-II and the newly discovered hemolysin gene HLP.

Authors:  S A Lachke; T Srikantha; L K Tsai; K Daniels; D R Soll
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  A histone deacetylation inhibitor and mutant promote colony-type switching of the human pathogen Candida albicans.

Authors:  A J Klar; T Srikantha; D R Soll
Journal:  Genetics       Date:  2001-06       Impact factor: 4.562

6.  Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure.

Authors:  B C Fries; D L Goldman; R Cherniak; R Ju; A Casadevall
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

7.  Phenotypic switching and genetic diversity of Cryptococcus neoformans.

Authors:  S Sukroongreung; S Lim; S Tantimavanich; B Eampokalap; D Carter; C Nilakul; S Kulkeratiyut; S Tansuphaswadikul
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

8.  Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection.

Authors:  M Feldmesser; Y Kress; P Novikoff; A Casadevall
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 9.  Phenotypic variation and intracellular parasitism by histoplasma Capsulatum.

Authors:  S Kügler; T Schurtz Sebghati; L Groppe Eissenberg; W E Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

10.  Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode.

Authors:  K Vargas; S A Messer; M Pfaller; S R Lockhart; J T Stapleton; J Hellstein; D R Soll
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

View more
  16 in total

1.  Aging: an emergent phenotypic trait that contributes to the virulence of Cryptococcus neoformans.

Authors:  Tejas Bouklas; Bettina C Fries
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

Review 2.  Synthesis of cell envelope glycoproteins of Cryptococcus laurentii.

Authors:  John Schutzbach; Helmut Ankel; Inka Brockhausen
Journal:  Carbohydr Res       Date:  2007-01-12       Impact factor: 2.104

3.  Gliotoxin in Aspergillus fumigatus: an example that mycotoxins are potential virulence factors.

Authors:  Herbert Hof; Claudio Kupfahl
Journal:  Mycotoxin Res       Date:  2009-08-11       Impact factor: 3.833

4.  Incorporation of 2-amino-thiophene derivative in nanoparticles: enhancement of antifungal activity.

Authors:  Wendell Wons Neves; Rejane Pereira Neves; Danielle Patrícia Cerqueira Macêdo; Giovanna Rodrigues de Araújo Eleamen; Elisângela Afonso de Moura Kretzschmar; Elquio Eleamen Oliveira; Francisco Jaime Bezerra Mendonça-Junior; Reginaldo Gonçalves de Lima-Neto
Journal:  Braz J Microbiol       Date:  2020-03-05       Impact factor: 2.476

Review 5.  Aging as an emergent factor that contributes to phenotypic variation in Cryptococcus neoformans.

Authors:  Tejas Bouklas; Bettina C Fries
Journal:  Fungal Genet Biol       Date:  2014-10-13       Impact factor: 3.495

6.  Nitrogen source-dependent capsule induction in human-pathogenic cryptococcus species.

Authors:  Aubrey E Frazzitta; Haily Vora; Michael S Price; Jennifer L Tenor; Marisol Betancourt-Quiroz; Dena L Toffaletti; Nan Cheng; John R Perfect
Journal:  Eukaryot Cell       Date:  2013-08-23

Review 7.  Molecular mechanisms of cryptococcal meningitis.

Authors:  Tong-Bao Liu; David S Perlin; Chaoyang Xue
Journal:  Virulence       Date:  2012-03-01       Impact factor: 5.882

8.  Capsule independent uptake of the fungal pathogen Cryptococcus neoformans into brain microvascular endothelial cells.

Authors:  Wilber Sabiiti; Robin C May
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

9.  Fungal biofilm morphology impacts hypoxia fitness and disease progression.

Authors:  Caitlin H Kowalski; Joshua D Kerkaert; Ko-Wei Liu; Matthew C Bond; Raimo Hartmann; Carey D Nadell; Jason E Stajich; Robert A Cramer
Journal:  Nat Microbiol       Date:  2019-09-23       Impact factor: 17.745

10.  Brain inositol is a novel stimulator for promoting Cryptococcus penetration of the blood-brain barrier.

Authors:  Tong-Bao Liu; Jong-Chul Kim; Yina Wang; Dena L Toffaletti; Eliseo Eugenin; John R Perfect; Kee Jun Kim; Chaoyang Xue
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.